Erratum: Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer

被引：0
|
作者：
F Al-Ejeh
P T Simpson
J M Saunus
K Klein
M Kalimutho
W Shi
M Miranda
J Kutasovic
A Raghavendra
J Madore
L Reid
L Krause
G Chenevix-Trench
S R Lakhani
K K Khanna
机构：
来源：
Oncogenesis | 2014年 / 3卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Correction to: Oncogenesis (2014) 3, e100; doi:10.1038/oncsis.2014.14; published online 21 April 2014 Since the publication of the above manuscript the authors have identified an error in the author list; the name of the third author was incorrectly presented. The corrected author list is shown above.
引用
收藏
页码：e124 / e124
相关论文
共 50 条
  • [1] Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer
    Al-Ejeh, F.
    Simpson, P. T.
    Sanus, J. M.
    Klein, K.
    Kalimutho, M.
    Shi, W.
    Miranda, M.
    Kutasovic, J.
    Raghavendra, A.
    Madore, J.
    Reid, L.
    Krause, L.
    Chenevix-Trench, G.
    Lakhani, S. R.
    Khanna, K. K.
    ONCOGENESIS, 2014, 3 : e100 - e100
  • [2] Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer
    F Al-Ejeh
    P T Simpson
    J M Sanus
    K Klein
    M Kalimutho
    W Shi
    M Miranda
    J Kutasovic
    A Raghavendra
    J Madore
    L Reid
    L Krause
    G Chenevix-Trench
    S R Lakhani
    K K Khanna
    Oncogenesis, 2014, 3 : e100 - e100
  • [3] Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer (vol 3, e100, 2014)
    Al-Ejeh, F.
    Simpson, P. T.
    Saunus, J. M.
    Klein, K.
    Kalimutho, M.
    Shi, W.
    Miranda, M.
    Kutasovic, J.
    Raghavendra, A.
    Madore, J.
    Reid, L.
    Krause, L.
    Chenevix-Trench, G.
    Lakhani, S. R.
    Khanna, K. K.
    ONCOGENESIS, 2014, 3 : e124 - e124
  • [4] Atezolizumab and pembrolizumab in triple-negative breast cancer: a meta-analysis
    Latif, Farah
    Jabbar, Hira Bint Abdul
    Malik, Hamna
    Sadaf, Humaira
    Sarfraz, Azza
    Sarfraz, Zouina
    Cherrez-Ojeda, Ivan
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (02) : 229 - 235
  • [5] The unique risk factor profile of triple-negative breast cancer: a comprehensive meta-analysis
    Kumar, Nitya
    Ehsan, Sarah
    Banerjee, Shahana
    Perez, Claudia Fernandez
    Lhuilier, Isabelle
    Neuner, Jillian
    Friebel-Klingner, Tara
    Fayanju, Oluwadamilola M.
    Nair, Bindhu
    Niinuma, Sara Anjum
    Nampoothiri, Shivangi
    McCarthy, Anne Marie
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2024, 116 (08): : 1210 - 1219
  • [6] THE GENE EXPRESSION PROFILE OF TRIPLE-NEGATIVE BREAST CANCER AFTER NEOADJUVANT CHEMOTHERAPY
    Philipovskiy, A.
    Gaur, S.
    Chambers, K.
    Gamez, R.
    McCallum, R.
    Kirken, R.
    Aguilera, R.
    Roy, S.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (02) : 440 - 440
  • [7] Platinum is essential in neoadjuvant treatment of triple-negative breast cancer: a network meta-analysis
    Junjie Li
    Li Chen
    Wei Tan
    Fang Qi
    Yang Zhang
    Zhonghua Wang
    Zhimin Shao
    Cancer Biology & Medicine, 2022, 19 (05) : 742 - 754
  • [8] Platinum is essential in neoadjuvant treatment of triple-negative breast cancer: a network meta-analysis
    Li, Junjie
    Chen, Li
    Tan, Wei
    Qi, Fang
    Zhang, Yang
    Wang, Zhonghua
    Shao, Zhimin
    CANCER BIOLOGY & MEDICINE, 2022, 19 (05) : 742 - 754
  • [9] Platinum-based therapy for triple-negative breast cancer treatment: A meta-analysis
    Tian, Muyou
    Zhong, Yahua
    Zhou, Fuxiang
    Xie, Conghua
    Zhou, Yunfeng
    Liao, Zhengkai
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (03) : 720 - 724
  • [10] Efficacy and Safety of Capecitabine for Triple-Negative Breast Cancer: A Meta-Analysis
    Xun, Xueqiong
    Cao, Qinguang
    Hong, Pan
    Rai, Saroj
    Zhou, Yeming
    Liu, Ruikang
    Hu, Huiyong
    FRONTIERS IN ONCOLOGY, 2022, 12
12345